Comparison of risperidone and olanzapine in the control of negative symptoms of chronic schizophrenia and related psychotic disorders in patients aged 50 to 65 years.

Feldman, Peter D; Kaiser, Christopher J; Kennedy, John S; Sutton, Virginia K; Tran, Pierre V; Tollefson, Gary D; Zhang, Fan; Breier, Alan

Feldman, Peter D; Kaiser, Christopher J; Kennedy, John S; Sutton, Virginia K; Tran, Pierre V; Tollefson, Gary D; Zhang, Fan; Breier, Alan.

Affiliation

Feldman PD; Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA. pdfeldman@lilly.com

J Clin Psychiatry ; 64(9): 998-1004, 2003 Sep.

Article in En | MEDLINE | ID: mdl-14628974

Subject(s)

Antipsychotic Agents/therapeutic use; Depression/drug therapy; Pirenzepine/analogs & derivatives; Pirenzepine/therapeutic use; Psychotic Disorders/drug therapy; Risperidone/therapeutic use; Schizophrenia/drug therapy; Schizophrenic Psychology; Adult; Age Factors; Aged; Antipsychotic Agents/adverse effects; Benzodiazepines; Chronic Disease; Depression/diagnosis; Depression/psychology; Double-Blind Method; Female; Humans; Male; Middle Aged; Olanzapine; Pirenzepine/adverse effects; Psychiatric Status Rating Scales; Psychotic Disorders/diagnosis; Psychotic Disorders/psychology; Risperidone/adverse effects; Schizophrenia/diagnosis; Treatment Outcome

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Psychotic Disorders / Schizophrenia / Schizophrenic Psychology / Antipsychotic Agents / Pirenzepine / Risperidone / Depression Type of study: Clinical_trials / Diagnostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Clin Psychiatry Year: 2003 Type: Article Affiliation country: United States

Search on Google

XML

PubMed Links